Go to ...

Nordens Ekonomi Norge

RSS Feed

18. november 2018

FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis


Euroinvestor.com A/S Euroinvestor.com A/S



FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis



Paris and Tarrytown, NY - November 6, 2018 - The U.S. ..

More Stories From

Do NOT follow this link or you will be banned from the site!
Read previous post:
AMG Advanced Metallurgical Group N.V. Publishes Agenda for Extraordinary General Meeting of Shareholders

   Amsterdam, 6 November 2018 (Regulated Information) --- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") has published the...

Close